Research and Markets (http://www.researchandmarkets.com/research/ch469m/central_nervous) has announced the addition of the "Central Nervous System (CNS) Tumor-Pipeline Insights, 2014" subscription to their offering.

This Central Nervous System (CNS) Tumor-Pipeline Insights, 2014, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Central Nervous System (CNS) Tumor.

This report provides information on the therapeutic development based on the Central Nervous System (CNS) Tumor dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information.

The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.

Key Topics Covered:

  1. Central Nervous System (CNS) Tumor Overview
  2. Central Nervous System (CNS) Tumor Pipeline Therapeutics
  3. Central Nervous System (CNS) Tumor Therapeutics under Development by Companies
  4. Central Nervous System (CNS) Tumor Late Stage Products (Filed and Phase III)
  5. Comparative Analysis
  6. Central Nervous System (CNS) Tumor Mid Clinical Stage Products (Phase II)
  7. Comparative Analysis
  8. Central Nervous System (CNS) Tumor Early Clinical Stage Products (Phase I and IND Filed)
  9. Comparative Analysis
  10. Central Nervous System (CNS) Tumor Discovery and Pre-Clinical Stage Products
  11. Comparative Analysis
  12. Drug Candidate Profiles
  13. Central Nervous System (CNS) Tumor - Therapeutics Assessment
  14. Assessment by Monotherapy Products
  15. Assessment by Combination Products
  16. Assessment by Route of Administration
  17. Assessment by Molecule Type
  18. Central Nervous System (CNS) Tumor - Discontinued Products
  19. Central Nervous System (CNS) Tumor - Dormant Products
  20. Companies Involved in Therapeutics Development for Central Nervous System (CNS) Tumor
  21. Appendix

For more information visit http://www.researchandmarkets.com/research/ch469m/central_nervous